Questions people ask about Abnehmspritze Genetik

The question about 'weight loss injection genetics' typically refers to GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy). Current consumer DNA tests (e.g., MyBody-X) do not include genes that directly predict efficacy or side effects of these drugs. While GWAS studies have identified variants in FTO, MC4R, and others linked to body weight regulation, their predictive power for individual response to GLP-1 agonists is not clinically validated. The evidence in this context is mostly mechanistic or marketing-driven; no robust clinical predictors are provided. Moreover, these injections are prescription-only and require medical supervision. A genetic test alone cannot guide therapy decisions. Safety note: self-medication without proper indication is risky. The answer remains conservative: genetics matter, but not yet in the practical application of weight loss injections.